LDLR and aortic aneurysm: Although we did not observe lipid dysfunction, we speculate that the NPC1L1 inhibitor likely mitigates the risk of iliac artery aneurysms via an unknown mechanism that might be related to an NPC1L1-specific pathway, which differs from the LDLR pathway.